To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa1902
Peptide Name Sequence 16 from Patent WO2024054009A1
Sequence DWLRIIWWWVCSVVSDFK
Sequence Length 18
Source HCV
Target Organism dengue virus
Patent Type Patent Application
Publication Date 2024-03-14
Patent No WO2024054009A1
Family Info KR20220114326A, KR2023013277W
Patent Title NOVEL ANTIVIRAL PEPTIDE
Comment
Abstract The present disclosure relates to an antiviral peptide and a use thereof. More specifically, the present disclosure pertains to a composition and method for treating viral diseases using an antiviral peptide.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.